Home/Filings/3/0001615774-19-002595
3//SEC Filing

RICE KENNETH L JR 3

Accession 0001615774-19-002595

CIK 0001711786other

Filed

Feb 14, 7:00 PM ET

Accepted

Feb 15, 7:44 AM ET

Size

11.7 KB

Accession

0001615774-19-002595

Insider Transaction Report

Form 3
Period: 2019-02-14
Holdings
  • Common Stock

    50,000
  • Common Stock

    (indirect: see footnote)
    726,943
Footnotes (1)
  • [F1]The securities are owned by Chelexa Biosciences, Inc. ("Chelexa"). Kenneth Rice is the Executive Chairman of Chelexa and in such capacity has voting and dispositive power of the securities held by such entity.

Issuer

Hoth Therapeutics, Inc.

CIK 0001711786

Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001126350

Filing Metadata

Form type
3
Filed
Feb 14, 7:00 PM ET
Accepted
Feb 15, 7:44 AM ET
Size
11.7 KB